Partner Courtenay Brinckerhoff was quoted in a BioWorld article, “With BPCIA Dance Optional, Next Moves Up to Biosimilar Sponsors,” on July 24, 2015. The article discussed next steps for biosimilar sponsors after the Federal Circuit confirmed that the Biologic Price Competition and Innovation Act’s intricate patent information exchange is optional. Brinckerhoff said it’s likely that many biosimilar developers will choose not to follow the steps in place by BPCIA since it requires the biosimilar sponsor to give a copy of its application and other confidential manufacturing-related information to the reigning market champion.
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"